Showing results (31-40 of 466) with videos related to
Sort By:
Pageof 47
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|September 14, 2002
Calcium channel blockade in combination with angiotensin-converting enzyme inhibition or angiotensin II (AT(1)-receptor) antagonism in hypertensive diabetics and patients with renal disease and hypertensionPhilip Swales, Bryan WilliamsHypertension Research : Official Journal of the Japanese Society of Hypertension|May 2, 2022
Angiotensin receptor-neprilysin inhibitors for hypertension-hemodynamic effects and relevance to hypertensive heart diseaseKazuomi Kario, Bryan WilliamsHypertension (Dallas, Tex. : 1979)|July 6, 2021
Nocturnal Hypertension and Heart Failure: Mechanisms, Evidence, and New TreatmentsKazuomi Kario, Bryan WilliamsBlood Pressure|January 17, 2012
The relationship of electrocardiographic left ventricular hypertrophy to decreased serum potassiumPeter M Okin, Sverre E Kjeldsen, Lars H Lindholm, et al.BMJ Open|August 9, 2015
Monotherapy versus dual therapy for the initial treatment of hypertension (PATHWAY-1): a randomised double-blind controlled trialThomas M MacDonald, Bryan Williams, Mark Caulfield, et al.Journal of Hypertension|October 3, 2002
High remaining risk in poorly treated hypertension: the 'rule of halves' still existsLars Weinehall, Bengt Ohgren, Mats Persson, et al.Journal of Hypertension|July 11, 2007
World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countriesShanthi Mendis, Lars H Lindholm, Giuseppe Mancia, et al.Journal of Hypertension|February 1, 2002
The regulation of human vascular smooth muscle extracellular matrix protein production by alpha- and beta-adrenoceptor stimulationChristopher J O'Callaghan, Bryan WilliamsJournal of the American College of Cardiology|August 15, 2009
Impact of heart rate on central aortic pressures and hemodynamics: analysis from the CAFE (Conduit Artery Function Evaluation) study: CAFE-Heart RateBryan Williams, Peter S Lacy, Lancet (London, England)|September 29, 2015
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trialBryan Williams, Thomas M MacDonald, Steve Morant, et al.Pageof 47